Literature DB >> 11728078

The effect of flurbiprofen and tiaprofenic acid on serum cytokine levels of patients with osteoarthrosis.

H Uzun1, S Tuzun, N Ozaras, S Aydin, R Ozaras, S Dondurmaci, F Tuzun.   

Abstract

39 patients with active knee osteoarthrosis, chosen according to ACR criteria, were assigned to receive flurbiprofen (n 12, 2 x 100 mg), tiaprofenic acid (n 14, 2 x 300 mg) and placebo (n 13) in a 3-week, placebo-controlled study. All patients completed the study, and both medications were found to be effective: improvement occurred in the clinical signs. These drugs reduced the TNF-alpha levels. Flurbiprofen especially affected the IL-6 levels. Our findings indicate that NSAIDs may be effective in the etiopathogenesis of osteoarthrosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11728078     DOI: 10.1080/000164701753532844

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  3 in total

Review 1.  Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials.

Authors:  Jan Magnus Bjordal; Anne Elisabeth Ljunggren; Atle Klovning; Lars Slørdal
Journal:  BMJ       Date:  2004-11-23

2.  Effects of flurbiprofen and tiaprofenic Acid on oxidative stress markers in osteoarthritis: A prospective, randomized, open-label, active- and placebo-controlled trial.

Authors:  Sansin Tuzun; Hafize Uzun; Seval Aydin; Ahmet Dinc; Sevtap Sipahi; Mehmet Ata Topcuoglu; Rifat Yucel; Ahmet Belce
Journal:  Curr Ther Res Clin Exp       Date:  2005-07

3.  In vivo study of pro-inflammatory cytokine changes in serum and synovial fluid during treatment with celecoxib and etoricoxib and correlation with VAS pain change and synovial membrane penetration index in patients with inflammatory arthritis.

Authors:  Athina Theodoridou; Helen Gika; Eudoxia Diza; Alexandros Garyfallos; Loucas Settas
Journal:  Mediterr J Rheumatol       Date:  2017-03-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.